Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Harvard Business School
Accenture
Argus Health
Merck
Colorcon
UBS
AstraZeneca
Deloitte
Julphar

Generated: April 23, 2018

DrugPatentWatch Database Preview

Details for Patent: 6,861,411

« Back to Dashboard

Which drugs does patent 6,861,411 protect, and when does it expire?

Patent 6,861,411 protects AZASITE and is included in one NDA.

This patent has nine patent family members in ten countries.
Summary for Patent: 6,861,411
Title: Method of treating eye infections with azithromycin
Abstract:The invention features methods and compositions for treating ocular infections. The method comprises topically administering to an eye of an animal in need of such treatment an ocular infection-treating amount of azithromycin.
Inventor(s): Ahmed; Imran (East Lyme, CT)
Assignee: Pfizer, Inc. (New York, NY)
Application Number:09/200,119
Patent Claim Types:
see list of patent claims
Use; Composition;

Drugs Protected by US Patent 6,861,411

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Oak Pharms Inc AZASITE azithromycin SOLUTION/DROPS;OPHTHALMIC 050810-001 Apr 27, 2007 RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial METHOD OF COMBATING BACTERIA IN A PATIENT ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Patents Family Members for US Patent 6,861,411

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Mexico 232591 ➤ Try a Free Trial
Japan H11240838 ➤ Try a Free Trial
Spain 2221127 ➤ Try a Free Trial
European Patent Office 0925789 ➤ Try a Free Trial
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

US Department of Justice
Fuji
Queensland Health
Medtronic
Federal Trade Commission
Daiichi Sankyo
Boehringer Ingelheim
Chinese Patent Office
Accenture

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.